250 related articles for article (PubMed ID: 29105752)
1. Buprenorphine in Neonatal Abstinence Syndrome.
Kraft WK
Clin Pharmacol Ther; 2018 Jan; 103(1):112-119. PubMed ID: 29105752
[TBL] [Abstract][Full Text] [Related]
2. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.
Kraft WK; Dysart K; Greenspan JS; Gibson E; Kaltenbach K; Ehrlich ME
Addiction; 2011 Mar; 106(3):574-80. PubMed ID: 20925688
[TBL] [Abstract][Full Text] [Related]
3. Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone.
Gaalema DE; Heil SH; Badger GJ; Metayer JS; Johnston AM
Drug Alcohol Depend; 2013 Nov; 133(1):266-9. PubMed ID: 23845658
[TBL] [Abstract][Full Text] [Related]
4. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.
Kraft WK; Gibson E; Dysart K; Damle VS; Larusso JL; Greenspan JS; Moody DE; Kaltenbach K; Ehrlich ME
Pediatrics; 2008 Sep; 122(3):e601-7. PubMed ID: 18694901
[TBL] [Abstract][Full Text] [Related]
5. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Abstinence Syndrome: Presentation and Treatment Considerations.
Jones HE; Kaltenbach K; Johnson E; Seashore C; Freeman E; Malloy E
J Addict Med; 2016; 10(4):224-8. PubMed ID: 27244045
[TBL] [Abstract][Full Text] [Related]
7. Interventions for the Treatment of Neonatal Abstinence Syndrome.
Cook CE; Fantasia HC
Nurs Womens Health; 2019 Aug; 23(4):357-365. PubMed ID: 31251931
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
McPherson C
Neonatal Netw; 2016; 35(5):314-20. PubMed ID: 27636696
[TBL] [Abstract][Full Text] [Related]
9. Breastfeeding promotion for management of neonatal abstinence syndrome.
Pritham UA
J Obstet Gynecol Neonatal Nurs; 2013; 42(5):517-26. PubMed ID: 24020477
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine: a newer drug for treating neonatal abstinence syndrome.
Bell SG
Neonatal Netw; 2012; 31(3):178-83. PubMed ID: 22564314
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
Kraft WK; Adeniyi-Jones SC; Chervoneva I; Greenspan JS; Abatemarco D; Kaltenbach K; Ehrlich ME
N Engl J Med; 2017 Jun; 376(24):2341-2348. PubMed ID: 28468518
[TBL] [Abstract][Full Text] [Related]
12. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
Jones HE; Heil SH; Baewert A; Arria AM; Kaltenbach K; Martin PR; Coyle MG; Selby P; Stine SM; Fischer G
Addiction; 2012 Nov; 107 Suppl 1(0 1):5-27. PubMed ID: 23106923
[TBL] [Abstract][Full Text] [Related]
14. The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome.
Moore JN; Gastonguay MR; Ng CM; Adeniyi-Jones SC; Moody DE; Fang WB; Ehrlich ME; Kraft WK
Clin Pharmacol Ther; 2018 Jun; 103(6):1029-1037. PubMed ID: 29516490
[TBL] [Abstract][Full Text] [Related]
15. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T
Clin Pharmacol Ther; 2022 Feb; 111(2):496-508. PubMed ID: 34679189
[TBL] [Abstract][Full Text] [Related]
16. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
Pritham UA; Paul JA; Hayes MJ
J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
[TBL] [Abstract][Full Text] [Related]
17. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
Debelak K; Morrone WR; O'Grady KE; Jones HE
Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
[TBL] [Abstract][Full Text] [Related]
19. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine compared with methadone in opioid-dependent pregnant women: How does it affect neonatal abstinence syndrome?
Bivin B; Waring A; Alves P
J Am Assoc Nurse Pract; 2019 Dec; 33(2):119-125. PubMed ID: 31809398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]